LP Portal
LP Portal

Unlocking
Human
Potential

HUMAN PERFORMANCE

JAZZ seeks breakthroughs at the convergence of technology, science, and humanity — improving how we live, work, and experience the world.

We are a team of experienced operators, technologists, scientists, and entrepreneurs who work together to make a positive difference.

Andrew Firlik

Andrew Firlik

Managing Partner

John F. Harris

John F. Harris

Managing Partner

Zack Lynch

Zack Lynch

Managing Partner

John Spinale

John Spinale

Managing Partner

John Lee

John Lee

Partner

Justin Nuñez

Justin Nuñez

Partner

Sharon Knight

Sharon Knight

Venture Partner

Chit-Kwan Lin

Chit-Kwan Lin

Venture Partner

Jia Li

Jia Li

Venture Partner

Ido Leffler

Ido Leffler

Venture Partner

Adam Gazzaley

Adam Gazzaley

Venture Partner

Sydney Cureton

Sydney Cureton

Senior Associate

Matt Wan

Matt Wan

Senior Associate

Sujude Dalieh

Sujude Dalieh

Senior Associate

Stone Connell

Stone Connell

Vice President of Finance

Diana Stoner

Diana Stoner

Director of Finance & Operations

Linda Michael

Linda Michael

Controller

Andrew Firlik
John F. Harris
Zack Lynch
John Spinale
John Lee
Justin Nuñez
Chris Flink
Sharon Knight
Chit-Kwan Lin
Jia Li
Ido Leffler
Adam Gazzaley
Sydney Cureton
Matt Wan
Sujude Dalieh
Stone Connell
Diana Stoner
Linda Michael
Andrew Firlik

Andrew Firlik

Managing Partner

Andrew has experience in venture capital, company building, technology development, and neurosurgery. He has served as founder, investor, director, and chairman of many successful companies.

Previously, he was a partner at Flare Capital Partners (formerly known as Foundation Medical Partners) and a principal at Canaan Partners. He was a founder and invented the core technology of Northstar Neuroscience, which went public and was subsequently acquired by St. Jude Medical. He also served as chairman of IntElect Medical, which was acquired by Boston Scientific. Andrew’s investments prior to JAZZ include BridgePoint Medical (acquired by Boston Scientific), Explorys (acquired by IBM), Functional Neuromodulation, and Visiogen (acquired by Abbott).

Prior to venture capital, Andrew was a board-certified neurosurgeon and served as clinical assistant professor of neurosurgery at Yale School of Medicine and New York University School of Medicine. During more than a decade in the healthcare profession, he published more than 50 medical articles and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. He has served on innovation advisory boards at Yale University, Cleveland Clinic, and Cornell University. Andrew earned his MD from Weill Cornell Medicine and his MBA from the University of Pittsburgh after studying neuroscience at Cornell (AB) and Oxford University.

Andrew serves on the boards of several technology, health, consumer, and enterprise companies in the JAZZ portfolio, including AllStripes, Blue Note Therapeutics, Cadence Neuroscience, Embodied, Magnus Medical, Mahana Therapeutics, Thrive Global, Woebot, Yumi, and Zus.

John F. Harris

John F. Harris

Managing Partner

John Harris is a seasoned investor, entrepreneur, executive, and corporate director with three decades of experience starting, developing, and directing early-stage life sciences and technology companies.

John’s board positions include Foresight Mental Health, Cadence Neuroscience, BlueNote Therapeutics, and HerMD. John is an empathetic, hands-on director who brings expertise in strategic analysis, leadership, creativity, concept development, product development, marketing, and finance.

Prior to JAZZ, John was the founder, president, and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. John was also a founder of Northstar Neuroscience, which went public in 2006 and was subsequently acquired by St. Jude Medical. Previous to that, John was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the global market leader and can be found in airports, sports arenas, public buildings, and many other locations. Heartstream went public in 1996 and was subsequently acquired by Hewlett-Packard.

John holds an engineering degree from Stanford, and an M.B.A. from Northwestern. He is passionate about fly-fishing and the outdoors, and lives with his wife in Medina, Washington.

Zack Lynch

Zack Lynch

Managing Partner

Zack is an entrepreneur and futurist who has deep insight into how emerging technologies impact industry and human society. He is a proactive board member and investor across a broad array of technology and health-related markets and enjoys helping innovators achieve their visions.

Before JAZZ, Zack built several companies focused on connecting industries including a global conference ecosystem that enabled thousands of startups to tap into new sources of capital. Needing to share his vision for the next 50 years, he wrote the global best-selling book, The Neuro Revolution: How Brain Science Is Changing Our World.

Zack has degrees in evolutionary biology and environmental science as well as a masters degree in economic geography all from UCLA. He sits on the boards of multiple consumer, enterprise and health-related companies across the JAZZ portfolio including: AppliedVR, JobGet, Swing Therapeutics and Pinpoint Predictive.

John Spinale

John Spinale

Managing Partner

John is a proven leader in consumer technology and digital media with a career focused on building, scaling and running high-growth companies of all sizes, from initial seed through to late-stage operation. He possesses a deep understanding of building brands, creating innovative experiences and leveraging new and emerging platforms.

Prior to JAZZ, John held senior operating roles in a wide array of technology companies in both the consumer and enterprise sectors. And in a distant past long forgotten, he earned a degree in engineering from Yale.

John sits on the boards of several companies in the JAZZ portfolio, including Outside, FormBio, and Sounding Board.

John Lee

John Lee

Partner

John is a seasoned investor, focusing on companies across frontier technology, enterprise software, robotics, healthcare, and artificial intelligence. He gravitates towards startups that are using science and technology to break down barriers to productivity growth and enable a better future for the largest number of people.

Prior to JAZZ, John was at Osage University Partners (OUP) and Lux Capital, where he focused on building and investing in companies at the intersection of science and deep technology. He brings extensive expertise in understanding nascent technologies and how they translate into product.

John’s prior investments and board roles include Algorithmia (acq. DataRobot), Body Labs (acq. AMZN), Corelight, Clarifai, Elementary ML, Embodied Robotics, Guardant Health (NYSE: GH), Kymeta, Menlo Security, SiFive, and Streetlight Data.

John holds a BS in Biology from Cornell University. John sits on the boards of several companies in the JAZZ portfolio, including Embodied, Rarebase, Oma Fertility, and Zeitworks.

Justin Nuñez

Justin Nuñez

Partner

Justin is an experienced leader in the alternative investment space, where he has focused his time building, scaling, and leading differentiated investment platforms in both public and private markets. Throughout his career, he has emphasized developing genuine, long-term relationships across the investment, media, and sports ecosystems. At JAZZ, Justin leads Capital Formation & Investor Relations, in addition to developing creative ways to expand the JAZZ platform and network.

Prior to JAZZ, Justin spent nearly a decade at TPG, a $150B global alternative investment firm. While at TPG, Justin held various senior leadership roles, including Partner & Head of Fundraising for TPG Public Equity Partners. He also co-founded TPG NEXT, a platform focused on investing in diverse entrepreneurs and investors. Justin helped lead TPG NEXT’s strategic investments in VamosVentures, LandSpire Group, and Harlem Capital.

Prior to TPG, Justin spent several years at Goldman Sachs and Lehman Brothers, where he started his career in Investment Banking.

Justin graduated from Columbia University with a B.A. in History and was a member of Columbia’s Division I-AA Football team for four years. In his final season at Columbia, Justin was an Arthur Ashe Sports Scholar Award Winner, and was also named to the inaugural National Football Foundation Honor Society.

Justin is an avid boxer and runner, but his true passion is spending his free time with his wife and two children.

Chris Flink

Chris Flink

Venture Partner

As a Venture Partner at JAZZ, Chris offers deep expertise in the design and development of compelling products, services and communications, and in the leadership of high-performing interdisciplinary teams. Chris advises portfolio companies on human-centered design, inspires them to create engaging user experiences, and helps craft narratives that resonate with the stakeholders that matter most to their success.

Chris is currently an adjunct professor at Stanford University, where he teaches a range of innovation-related courses (in both the School of Engineering and the Graduate School of Business), is a founding faculty member of its renowned “d.school”, and previously earned degrees in engineering, product design, and business.

From 2016 to 2022, Chris was the CEO and Executive Director of the Exploratorium, SF’s pioneering museum of science, art and human perception. Prior to that, he was a senior partner at IDEO, collaboratively designing countless innovative products and co-leading the firm’s Consumer Experience Design practice. Chris enjoyed early entrepreneurial success as an independent inventor and has also served on Fortune 500 public company boards. He relishes opportunities to draw on his diverse experience to help JAZZ portfolio companies get unstuck, shift perspective, and make creative efforts that have meaningful strategic impact.

Sharon Knight

Sharon Knight

Venture Partner

Sharon is a wellness and healthy aging champion with deep experience in finance, planning and operations that she deploys as a growth and operations strategist for healthcare and health tech startups.

After leading finance and development functions and multi-national teams at KFC, Gap, and Electronic Arts, she joined One Medical Group, which went public in 2020 and is now owned by Amazon, as President. After overseeing the clinic’s growth beyond San Francisco to NYC, Washington, Boston and Chicago, Sharon served as COO of The Plant Café Organic, championing food as medicine, and President and COO of Hawthorne Effect, which is transforming how clinical trials are conducted. Most recently, she led Stop the Spread, a COVID-19 response nonprofit formed to catalyze the private sector’s response to the pandemic with support from Impact Assets and Google.org.

Sharon holds an MBA in Finance from Northwestern University and a BA in Economics from Smith College.

Chit-Kwan Lin

Chit-Kwan Lin

Venture Partner

Chit-Kwan (CK) brings to JAZZ deeply technical expertise, drawn from over twenty years in academic and industry settings, spanning machine learning, computer architecture, distributed computing, cyber-physical systems, wireless networking, software engineering, and healthcare tech. Trained as a computer scientist, with dozens of peer-reviewed publications and patents, he has a passion for research commercialization and most enjoys building teams that turn lab innovations into useful products.

Currently, CK is the founder and CEO of Revelata, Inc., a natural language processing startup serving the finance industry. Previously, CK was at Intel Corporation, where he was responsible for the first API and compiler for Loihi, Intel’s (non-von Neumann) neuromorphic research chip, and where he subsequently led the Smart Computing Architecture Team in its effort to improve CPU performance by directly incorporating machine learning into Intel microarchitecture. Earlier in his career, CK worked on advanced protocols for drone and satellite networks at Harvard and MIT Lincoln Lab, and was a software engineer for many years at various startups.

CK holds an A.B. in Biochemical Sciences, and S.M., and Ph.D. degrees in Computer Science, all from Harvard University.

Jia Li

Jia Li

Venture Partner

Jia is interested in how AI will make positive impact on everyday life. She is an entrepreneur who is excited about bringing Generative AI to real-world applications. Most recently she is the Co-Founder, Chief AI Officer and President of LiveX AI, which aims to transform the way we live towards a smart, sustainable, and an enjoyable home environment.

Previously, she was the Founding Global Head of R&D at Google Cloud AI. At Google, she oversaw the development of the full stack of AI products on Google Cloud to power solutions for diverse industries. Before joining Google, Jia was the Head of Research at Snap, leading the AI/AR innovation effort.

With the passion to make more impact to our everyday life, she has also had a distinguished career building and advising companies with award-winning platforms to solve today’s greatest challenges across many industries and disciplines. She has served as Mentor and Professor-in-Residence at StartX, advising founders/companies from Stanford alumni. She is the Co-Founder and Chairperson of HealthUnity Corporation, a volunteer-based nonprofit organization. She served at Accenture as a part-time Chief AI Fellow for the Generative AI strategy. She also serves as an advisor to the United Nations Children’s Fund (UNICEF). She is a board member of the Children’s Discovery Museum of San Jose.  She was elected as IEEE Fellow for Leadership in Large Scale AI. She co-taught the inaugural course of Generative AI and Medicine at Stanford University, where she has served multiple roles, including Advisory Board Committee to Nourish, Chief AI Fellow, Fellow of RWE for Sleep Health, and has also served as Adjunct Professor at the Stanford School of Medicine.

She received her Ph.D. degree from the Computer Science Department at Stanford University.

Ido Leffler

Ido Leffler

Venture Partner

Ido has long and successful experience in developing and investing in consumer and digital brands. He has extensive networks in the start-up communities of Silicon Valley and Australasia.

Ido is the co-founder at Yoobi, a school supplies company that engages kids through bright colours, cool designs and, most importantly, cause: Yoobi has provided free school supplies to over 5.5 million kids. He is also a co-founder of Beach House Group – a global consumer product house.

Ido is a non-executive director of Vestergaard, Southern Cross Austereo, Yumi and The Lux Group. Previously Ido was non-executive director of Spark New Zealand Limited (Formerly Telecom NZ) from 2012-2020.

He sits on other corporate and advisory boards, including as an emeritus member of the United Nations Foundation Global Entrepreneur Council.

Adam Gazzaley

Adam Gazzaley

Venture Partner

Adam currently serves as a Venture Partner at JAZZ where he advises the firm and its portfolio companies on scientific, research and technological operations. Adam is lab director and professor of neurology, physiology and psychiatry at University of California, San Francisco.

He received his M.D. and Ph.D. degrees in Neuroscience through the NIH-sponsored Medical Scientist Training Program at the Mount Sinai School of Medicine in New York. He went on to complete an internship in internal medicine and residency in neurology at the University of Pennsylvania. Following residency, Dr. Gazzaley was awarded a research fellowship at University of California, Berkeley where he worked with Dr. Mark D’Esposito and Dr. Robert Knight. The research involved studying memory and attention in humans and the changes that occur with normal aging using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). During this time, he also completed a clinical fellowship in cognitive neurology at the Memory and Aging Center, under the direction of Dr. Bruce Miller, and became board-certified in neurology.

Adam is the founding director of the Neuroscience Imaging Center at the University of California, San Francisco; an Associate Professor in Neurology, Physiology and Psychiatry; and Principal Investigator of a cognitive neuroscience laboratory. His laboratory studies neural mechanisms of perception, attention and memory, with an emphasis on the impact of distraction and multitasking on these abilities. His unique research approach utilizes a powerful combination of human neurophysiological tools, including fMRI, EEG and transcranial stimulation (TES). Through this research, Adam has been able to expand our understanding of alterations in the aging brain that lead to cognitive decline. His most recent studies explore how we may enhance our cognitive abilities via engagement with custom-designed video games, neurofeedback and TES.

Adam has authored over 100 scientific articles, delivered almost 400 presentations globally, including TED and TEDMED, and his research and perspectives have been consistently profiled in national and international media outlets that include The New York Times, New Yorker, Wired, NBC Nightly News, and others. Recently Adam wrote and hosted the nationally televised, PBS-sponsored special “The Distracted Mind with Dr. Adam Gazzaley.”

Sydney Cureton

Sydney Cureton

Senior Associate

Sydney’s background is in helping growing businesses raise capital, and prior to JAZZ she worked in investment banking at Morgan Stanley in both New York and London. As part of the Equity Capital Markets division, she focused her time on technology and business services, and helped a range of companies IPO and raise equity capital in the public markets.

Sydney holds a degree in Economics from Yale, where she was a sprinter and Captain of the Women’s Varsity Track and Field team.

She is passionate about supporting inclusion among early stage founders and investors and is actively involved with several groups including All Raise.

Matt Wan

Matt Wan

Senior Associate

Matt is an experienced entrepreneur with a passion for health and human performance.

Prior to joining JAZZ, Matt was the Founder and CEO of Momentous, a performance nutrition company that he started at 18 and dropped out of Harvard to build. He led the company through several rounds of venture funding to become a trusted consumer brand and the leading supplier of supplements and nutrition products for professional and collegiate sports teams in the US. Momentous was acquired by Amp Human in 2021, after which Matt shifted to the role of Chief Product Officer to help manage the company’s transition.

Outside of JAZZ, Matt is an avid endurance athlete, an active angel investor and a minority owner in Leeds United Football Club.

Sujude Dalieh

Sujude Dalieh

Senior Associate

Sujude Dalieh is an investor at JAZZ where she invests at the intersection of cultural trends and deep science.

Prior to JAZZ, Sujude supported investments across fronteir tech, workforce solutions, and health innovations at Lux Capital and K50 Ventures. Sujude started her career off in the computational sciences and is a Berkeley-trained scientist. She was a member of the Somorjai Group, a surface chemistry research lab at the Lawrence Berkeley National Laboratory, and she subsequently led the integration of the Jupyter Project at the Berkeley Institute of Data Science across over 50 clients. She pivoted to digital product strategy, where she built an array of community-forward health initiatives at Hopelab and YTH.

Sujude holds an MEng in Product Design Engineering from Stanford University and a BS in Chemistry from UC Berkeley and currently guest lectures at both institutions. Sujude currently sits on the boards of Mercaso and JobGet and is active in the MENA-affiliated startup world as a member of TechWadi.

Stone Connell

Stone Connell

Vice President of Finance

Stone Connell is the VP of Finance for JAZZ Venture Partners where he leads the finance, accounting, and operational functions of the firm. Prior to joining JAZZ, Stone served as the Director of Finance for Biomatics Capital, a life sciences venture capital firm, where he managed the financial, reporting, and administrative activities.

Previously, Stone was an engagement manager with the fund administrator, Standish Management, serving clients across the private equity industry. He began his career with PwC as an auditor within the asset management line of service. At PwC he provided audit and consulting services to clients ranging from large hedge funds to local private equity managers in the Seattle market.

Stone is a Certified Public Accountant and earned his B.A. in Business Administration (Accounting emphasis) as well as his Masters in Accountancy from the University of Washington – Seattle.

Outside of work, you’ll find Stone outdoors with his family hiking, skiing, running or exploring outdoors. He is also an avid sports fan and always enjoys going to a local game.

Diana Stoner

Diana Stoner

Director of Finance & Operations

Diana Stoner serves as Director of Finance and Operations for JAZZ Venture Partners, where she supports the finance, accounting, and operational functions of the firm.

Prior to joining JAZZ, Diana spent her career in Accounting at alternative investment firm HBK Capital Management in Dallas, Texas. Diana is a Certified Public Accountant and earned her B.S. in Accounting and M.S. in Management from Texas A&M University.

Linda Michael

Linda Michael

Controller

Linda Michael serves as Controller for JAZZ Venture Partners where she supports the finance, accounting, and operational functions for JAZZ with decades of experience in the space.

Previously, Linda spent time in both public accounting, at Deloitte in Seattle, and in corporate financial reporting at Immunex Corporation. Following these roles, she assumed fund administration roles for both Aduro Advisors and XFO Partners. Linda has also been actively involved in various philanthropic and finance positions in her community.

Linda graduated cum laude from the University of Washington Foster School of Business in June 1990, with a major in Business Administration and Concentration in Accounting.

Linda enjoys traveling with her family and cheering on Husky football.

Andrew Firlik

Managing Partner

Andrew has experience in venture capital, company building, technology development, and neurosurgery. He has served as founder, investor, director, and chairman of many successful companies.

Previously, he was a partner at Flare Capital Partners (formerly known as Foundation Medical Partners) and a principal at Canaan Partners. He was a founder and invented the core technology of Northstar Neuroscience, which went public and was subsequently acquired by St. Jude Medical. He also served as chairman of IntElect Medical, which was acquired by Boston Scientific. Andrew’s investments prior to JAZZ include BridgePoint Medical (acquired by Boston Scientific), Explorys (acquired by IBM), Functional Neuromodulation, and Visiogen (acquired by Abbott).

Prior to venture capital, Andrew was a board-certified neurosurgeon and served as clinical assistant professor of neurosurgery at Yale School of Medicine and New York University School of Medicine. During more than a decade in the healthcare profession, he published more than 50 medical articles and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. He has served on innovation advisory boards at Yale University, Cleveland Clinic, and Cornell University. Andrew earned his MD from Weill Cornell Medicine and his MBA from the University of Pittsburgh after studying neuroscience at Cornell (AB) and Oxford University.

Andrew serves on the boards of several technology, health, consumer, and enterprise companies in the JAZZ portfolio, including AllStripes, Blue Note Therapeutics, Cadence Neuroscience, Embodied, Magnus Medical, Mahana Therapeutics, Thrive Global, Woebot, Yumi, and Zus.

John F. Harris

Managing Partner

John Harris is a seasoned investor, entrepreneur, executive, and corporate director with three decades of experience starting, developing, and directing early-stage life sciences and technology companies.

John’s board positions include Foresight Mental Health, Cadence Neuroscience, BlueNote Therapeutics, and HerMD. John is an empathetic, hands-on director who brings expertise in strategic analysis, leadership, creativity, concept development, product development, marketing, and finance.

Prior to JAZZ, John was the founder, president, and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. John was also a founder of Northstar Neuroscience, which went public in 2006 and was subsequently acquired by St. Jude Medical. Previous to that, John was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the global market leader and can be found in airports, sports arenas, public buildings, and many other locations. Heartstream went public in 1996 and was subsequently acquired by Hewlett-Packard.

John holds an engineering degree from Stanford, and an M.B.A. from Northwestern. He is passionate about fly-fishing and the outdoors, and lives with his wife in Medina, Washington.

Zack Lynch

Managing Partner

Zack is an entrepreneur and futurist who has deep insight into how emerging technologies impact industry and human society. He is a proactive board member and investor across a broad array of technology and health-related markets and enjoys helping innovators achieve their visions.

Before JAZZ, Zack built several companies focused on connecting industries including a global conference ecosystem that enabled thousands of startups to tap into new sources of capital. Needing to share his vision for the next 50 years, he wrote the global best-selling book, The Neuro Revolution: How Brain Science Is Changing Our World.

Zack has degrees in evolutionary biology and environmental science as well as a masters degree in economic geography all from UCLA. He sits on the boards of multiple consumer, enterprise and health-related companies across the JAZZ portfolio including: AppliedVR, JobGet, Swing Therapeutics and Pinpoint Predictive.

John Spinale

Managing Partner

John is a proven leader in consumer technology and digital media with a career focused on building, scaling and running high-growth companies of all sizes, from initial seed through to late-stage operation. He possesses a deep understanding of building brands, creating innovative experiences and leveraging new and emerging platforms.

Prior to JAZZ, John held senior operating roles in a wide array of technology companies in both the consumer and enterprise sectors. And in a distant past long forgotten, he earned a degree in engineering from Yale.

John sits on the boards of several companies in the JAZZ portfolio, including Outside, FormBio, and Sounding Board.

John Lee

Partner

John is a seasoned investor, focusing on companies across frontier technology, enterprise software, robotics, healthcare, and artificial intelligence. He gravitates towards startups that are using science and technology to break down barriers to productivity growth and enable a better future for the largest number of people.

Prior to JAZZ, John was at Osage University Partners (OUP) and Lux Capital, where he focused on building and investing in companies at the intersection of science and deep technology. He brings extensive expertise in understanding nascent technologies and how they translate into product.

John’s prior investments and board roles include Algorithmia (acq. DataRobot), Body Labs (acq. AMZN), Corelight, Clarifai, Elementary ML, Embodied Robotics, Guardant Health (NYSE: GH), Kymeta, Menlo Security, SiFive, and Streetlight Data.

John holds a BS in Biology from Cornell University. John sits on the boards of several companies in the JAZZ portfolio, including Embodied, Rarebase, Oma Fertility, and Zeitworks.

Justin Nuñez

Partner

Justin is an experienced leader in the alternative investment space, where he has focused his time building, scaling, and leading differentiated investment platforms in both public and private markets. Throughout his career, he has emphasized developing genuine, long-term relationships across the investment, media, and sports ecosystems. At JAZZ, Justin leads Capital Formation & Investor Relations, in addition to developing creative ways to expand the JAZZ platform and network.

Prior to JAZZ, Justin spent nearly a decade at TPG, a $150B global alternative investment firm. While at TPG, Justin held various senior leadership roles, including Partner & Head of Fundraising for TPG Public Equity Partners. He also co-founded TPG NEXT, a platform focused on investing in diverse entrepreneurs and investors. Justin helped lead TPG NEXT’s strategic investments in VamosVentures, LandSpire Group, and Harlem Capital.

Prior to TPG, Justin spent several years at Goldman Sachs and Lehman Brothers, where he started his career in Investment Banking.

Justin graduated from Columbia University with a B.A. in History and was a member of Columbia’s Division I-AA Football team for four years. In his final season at Columbia, Justin was an Arthur Ashe Sports Scholar Award Winner, and was also named to the inaugural National Football Foundation Honor Society.

Justin is an avid boxer and runner, but his true passion is spending his free time with his wife and two children.

Chris Flink

Venture Partner

As a Venture Partner at JAZZ, Chris offers deep expertise in the design and development of compelling products, services and communications, and in the leadership of high-performing interdisciplinary teams. Chris advises portfolio companies on human-centered design, inspires them to create engaging user experiences, and helps craft narratives that resonate with the stakeholders that matter most to their success.

Chris is currently an adjunct professor at Stanford University, where he teaches a range of innovation-related courses (in both the School of Engineering and the Graduate School of Business), is a founding faculty member of its renowned “d.school”, and previously earned degrees in engineering, product design, and business.

From 2016 to 2022, Chris was the CEO and Executive Director of the Exploratorium, SF’s pioneering museum of science, art and human perception. Prior to that, he was a senior partner at IDEO, collaboratively designing countless innovative products and co-leading the firm’s Consumer Experience Design practice. Chris enjoyed early entrepreneurial success as an independent inventor and has also served on Fortune 500 public company boards. He relishes opportunities to draw on his diverse experience to help JAZZ portfolio companies get unstuck, shift perspective, and make creative efforts that have meaningful strategic impact.

Sharon Knight

Venture Partner

Sharon is a wellness and healthy aging champion with deep experience in finance, planning and operations that she deploys as a growth and operations strategist for healthcare and health tech startups.

After leading finance and development functions and multi-national teams at KFC, Gap, and Electronic Arts, she joined One Medical Group, which went public in 2020 and is now owned by Amazon, as President. After overseeing the clinic’s growth beyond San Francisco to NYC, Washington, Boston and Chicago, Sharon served as COO of The Plant Café Organic, championing food as medicine, and President and COO of Hawthorne Effect, which is transforming how clinical trials are conducted. Most recently, she led Stop the Spread, a COVID-19 response nonprofit formed to catalyze the private sector’s response to the pandemic with support from Impact Assets and Google.org.

Sharon holds an MBA in Finance from Northwestern University and a BA in Economics from Smith College.

Chit-Kwan Lin

Venture Partner

Chit-Kwan (CK) brings to JAZZ deeply technical expertise, drawn from over twenty years in academic and industry settings, spanning machine learning, computer architecture, distributed computing, cyber-physical systems, wireless networking, software engineering, and healthcare tech. Trained as a computer scientist, with dozens of peer-reviewed publications and patents, he has a passion for research commercialization and most enjoys building teams that turn lab innovations into useful products.

Currently, CK is the founder and CEO of Revelata, Inc., a natural language processing startup serving the finance industry. Previously, CK was at Intel Corporation, where he was responsible for the first API and compiler for Loihi, Intel’s (non-von Neumann) neuromorphic research chip, and where he subsequently led the Smart Computing Architecture Team in its effort to improve CPU performance by directly incorporating machine learning into Intel microarchitecture. Earlier in his career, CK worked on advanced protocols for drone and satellite networks at Harvard and MIT Lincoln Lab, and was a software engineer for many years at various startups.

CK holds an A.B. in Biochemical Sciences, and S.M., and Ph.D. degrees in Computer Science, all from Harvard University.

Jia Li

Venture Partner

Jia is interested in how AI will make positive impact on everyday life. She is an entrepreneur who is excited about bringing Generative AI to real-world applications. Most recently she is the Co-Founder, Chief AI Officer and President of LiveX AI, which aims to transform the way we live towards a smart, sustainable, and an enjoyable home environment.

Previously, she was the Founding Global Head of R&D at Google Cloud AI. At Google, she oversaw the development of the full stack of AI products on Google Cloud to power solutions for diverse industries. Before joining Google, Jia was the Head of Research at Snap, leading the AI/AR innovation effort.

With the passion to make more impact to our everyday life, she has also had a distinguished career building and advising companies with award-winning platforms to solve today’s greatest challenges across many industries and disciplines. She has served as Mentor and Professor-in-Residence at StartX, advising founders/companies from Stanford alumni. She is the Co-Founder and Chairperson of HealthUnity Corporation, a volunteer-based nonprofit organization. She served at Accenture as a part-time Chief AI Fellow for the Generative AI strategy. She also serves as an advisor to the United Nations Children’s Fund (UNICEF). She is a board member of the Children’s Discovery Museum of San Jose.  She was elected as IEEE Fellow for Leadership in Large Scale AI. She co-taught the inaugural course of Generative AI and Medicine at Stanford University, where she has served multiple roles, including Advisory Board Committee to Nourish, Chief AI Fellow, Fellow of RWE for Sleep Health, and has also served as Adjunct Professor at the Stanford School of Medicine.

She received her Ph.D. degree from the Computer Science Department at Stanford University.

Ido Leffler

Venture Partner

Ido has long and successful experience in developing and investing in consumer and digital brands. He has extensive networks in the start-up communities of Silicon Valley and Australasia.

Ido is the co-founder at Yoobi, a school supplies company that engages kids through bright colours, cool designs and, most importantly, cause: Yoobi has provided free school supplies to over 5.5 million kids. He is also a co-founder of Beach House Group – a global consumer product house.

Ido is a non-executive director of Vestergaard, Southern Cross Austereo, Yumi and The Lux Group. Previously Ido was non-executive director of Spark New Zealand Limited (Formerly Telecom NZ) from 2012-2020.

He sits on other corporate and advisory boards, including as an emeritus member of the United Nations Foundation Global Entrepreneur Council.

Adam Gazzaley

Venture Partner

Adam currently serves as a Venture Partner at JAZZ where he advises the firm and its portfolio companies on scientific, research and technological operations. Adam is lab director and professor of neurology, physiology and psychiatry at University of California, San Francisco.

He received his M.D. and Ph.D. degrees in Neuroscience through the NIH-sponsored Medical Scientist Training Program at the Mount Sinai School of Medicine in New York. He went on to complete an internship in internal medicine and residency in neurology at the University of Pennsylvania. Following residency, Dr. Gazzaley was awarded a research fellowship at University of California, Berkeley where he worked with Dr. Mark D’Esposito and Dr. Robert Knight. The research involved studying memory and attention in humans and the changes that occur with normal aging using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). During this time, he also completed a clinical fellowship in cognitive neurology at the Memory and Aging Center, under the direction of Dr. Bruce Miller, and became board-certified in neurology.

Adam is the founding director of the Neuroscience Imaging Center at the University of California, San Francisco; an Associate Professor in Neurology, Physiology and Psychiatry; and Principal Investigator of a cognitive neuroscience laboratory. His laboratory studies neural mechanisms of perception, attention and memory, with an emphasis on the impact of distraction and multitasking on these abilities. His unique research approach utilizes a powerful combination of human neurophysiological tools, including fMRI, EEG and transcranial stimulation (TES). Through this research, Adam has been able to expand our understanding of alterations in the aging brain that lead to cognitive decline. His most recent studies explore how we may enhance our cognitive abilities via engagement with custom-designed video games, neurofeedback and TES.

Adam has authored over 100 scientific articles, delivered almost 400 presentations globally, including TED and TEDMED, and his research and perspectives have been consistently profiled in national and international media outlets that include The New York Times, New Yorker, Wired, NBC Nightly News, and others. Recently Adam wrote and hosted the nationally televised, PBS-sponsored special “The Distracted Mind with Dr. Adam Gazzaley.”

Sydney Cureton

Senior Associate

Sydney’s background is in helping growing businesses raise capital, and prior to JAZZ she worked in investment banking at Morgan Stanley in both New York and London. As part of the Equity Capital Markets division, she focused her time on technology and business services, and helped a range of companies IPO and raise equity capital in the public markets.

Sydney holds a degree in Economics from Yale, where she was a sprinter and Captain of the Women’s Varsity Track and Field team.

She is passionate about supporting inclusion among early stage founders and investors and is actively involved with several groups including All Raise.

Matt Wan

Senior Associate

Matt is an experienced entrepreneur with a passion for health and human performance.

Prior to joining JAZZ, Matt was the Founder and CEO of Momentous, a performance nutrition company that he started at 18 and dropped out of Harvard to build. He led the company through several rounds of venture funding to become a trusted consumer brand and the leading supplier of supplements and nutrition products for professional and collegiate sports teams in the US. Momentous was acquired by Amp Human in 2021, after which Matt shifted to the role of Chief Product Officer to help manage the company’s transition.

Outside of JAZZ, Matt is an avid endurance athlete, an active angel investor and a minority owner in Leeds United Football Club.

Sujude Dalieh

Senior Associate

Sujude Dalieh is an investor at JAZZ where she invests at the intersection of cultural trends and deep science.

Prior to JAZZ, Sujude supported investments across fronteir tech, workforce solutions, and health innovations at Lux Capital and K50 Ventures. Sujude started her career off in the computational sciences and is a Berkeley-trained scientist. She was a member of the Somorjai Group, a surface chemistry research lab at the Lawrence Berkeley National Laboratory, and she subsequently led the integration of the Jupyter Project at the Berkeley Institute of Data Science across over 50 clients. She pivoted to digital product strategy, where she built an array of community-forward health initiatives at Hopelab and YTH.

Sujude holds an MEng in Product Design Engineering from Stanford University and a BS in Chemistry from UC Berkeley and currently guest lectures at both institutions. Sujude currently sits on the boards of Mercaso and JobGet and is active in the MENA-affiliated startup world as a member of TechWadi.

Stone Connell

Vice President of Finance

Stone Connell is the VP of Finance for JAZZ Venture Partners where he leads the finance, accounting, and operational functions of the firm. Prior to joining JAZZ, Stone served as the Director of Finance for Biomatics Capital, a life sciences venture capital firm, where he managed the financial, reporting, and administrative activities.

Previously, Stone was an engagement manager with the fund administrator, Standish Management, serving clients across the private equity industry. He began his career with PwC as an auditor within the asset management line of service. At PwC he provided audit and consulting services to clients ranging from large hedge funds to local private equity managers in the Seattle market.

Stone is a Certified Public Accountant and earned his B.A. in Business Administration (Accounting emphasis) as well as his Masters in Accountancy from the University of Washington – Seattle.

Outside of work, you’ll find Stone outdoors with his family hiking, skiing, running or exploring outdoors. He is also an avid sports fan and always enjoys going to a local game.

Diana Stoner

Director of Finance & Operations

Diana Stoner serves as Director of Finance and Operations for JAZZ Venture Partners, where she supports the finance, accounting, and operational functions of the firm.

Prior to joining JAZZ, Diana spent her career in Accounting at alternative investment firm HBK Capital Management in Dallas, Texas. Diana is a Certified Public Accountant and earned her B.S. in Accounting and M.S. in Management from Texas A&M University.

Linda Michael

Controller

Linda Michael serves as Controller for JAZZ Venture Partners where she supports the finance, accounting, and operational functions for JAZZ with decades of experience in the space.

Previously, Linda spent time in both public accounting, at Deloitte in Seattle, and in corporate financial reporting at Immunex Corporation. Following these roles, she assumed fund administration roles for both Aduro Advisors and XFO Partners. Linda has also been actively involved in various philanthropic and finance positions in her community.

Linda graduated cum laude from the University of Washington Foster School of Business in June 1990, with a major in Business Administration and Concentration in Accounting.

Linda enjoys traveling with her family and cheering on Husky football.

JAZZ partners with early and growth stage companies in enterprise, wellness, healthcare, and consumer markets.

  • View all
  • Health
  • Productivity
air

AIR uses closed-loop interactions to provide a robust training platform for humans and AI agents to collaborate and learn together.

akili

IPO. Akili Interactive develops scientifically validated, entertaining videogames designed to improve mental capabilities.

all-stripes

ACQUIRED. AllStripes is a digital research platform for unlocking new treatments for people with rare disease.

applied-vr

AppliedVR is pioneering next-generation prescription digital therapeutics for pain management and mental health.

arrival-health

Arrive Health provides critical information and clinical decision support technology at the point of care.

augment

Augment leverages AI to supercharge human productivity.

BioDrive is a gene editing company developing supplements that improve human health and wellness.

blue-note-therapeutics

Blue Note leverages cutting-edge digital technology and neuroscience for the treatment of serious medical conditions.

cadence-neuroscience

Cadence Neuroscience is developing a brain-computer interface (BCI) platform to treat a wide range of neurological disorders.

colossal

Colossal is a technology-driven biosciences platform advancing CRISPR technology to increase biodiversity and treat disease.

count

Count Technologies is developing AI-enabled tools to augment workforce productivity in financial services.

embodied

Embodied is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care.

enveda-biosciences

Enveda Biosciences leverages AI and metabolomics to translate molecules found in nature into new therapeutics.

eye-fluence

ACQUIRED. Eyefluence created the world’s first eye-interaction solution for augmented and virtual reality devices.

form-bio

Form Bio is the new operating system for the biological sciences.

forsight

Foresight augments human performance by providing state-of-the-art technology-driven mental healthcare services.

free-letics

Freeletics is the market leader in personalized coaching intelligence for optimizing physical fitness.

genesis-therapeutics

Genesis Therapeutics leverages machine learning to accelerate and optimize the discovery and development of new medicines.

halo-neuroscience

ACQUIRED. Halo Neuroscience uses brain stimulation to improve physical performance.

her-MD

HerMD is a technology-enabled female-focused provider of comprehensive and empathic healthcare for women.

human-co

HumanCo builds products focused on sustainable healthier living.

insight-timer

Insight Timer is a global meditation marketplace with over 40,000 guided meditations and 25 million members.

intuition

Intuition is a technology platform that drives human performance and wellness in the workplace.

job-get

JobGet is a mobile social jobs platform for the 82 million hourly workers in the US.

klowen

KLOwen is creating the future of digitally-enabled orthodontia.

League1 is establishing a first-of-its-kind sports league focused on fan experience and athlete safety.

level-ex

ACQUIRED. Level Ex creates industry-leading mobile and AR training software and games for physicians.

limbix

ACQUIRED. Limbix develops software to treat adolescent mental health.

magic-mind

Magic Mind provides clinically validated alternatives to high-caffeine energy drinks to improve cognitive function and wellbeing.

magnus-medical

Magnus Medical is developing closed-loop neuromodulation technology to treat intractable neurological and psychiatric disorders.

mahana

Mahana is developing breakthrough digital therapeutics that treat diseases, relieve suffering, and improve human performance.

mercaso

Mercaso develops software and automation technology to unlock the potential of small businesses.

merly_ai

Merly develops machine programming software intended to automate software development and improve software quality.

nextstep

ACQUIRED. NextStep developed accelerated learning technology to enable workers in less-skilled jobs to unlock their full potential.

oma-fertility

ACQUIRED. Oma has clinics that offer empathic care powered by AI technologies to increase IVF success rates at much lower costs.

oura

Oura is the leader in technologies that analyze sleep and activity to optimize human performance.

outside

Outside is the leader in technology and media innovation for active lifestyle enthusiasts.

pear-therapeutics

IPO. Pear Therapeutics is pioneering the development of prescription digital therapeutics.

Picnic-Health

PicnicHealth collects, digitizes, and encrypts all your medical records—then arranges everything in one intuitive timeline.

pinpoint

Pinpoint Predictive leverages neuroscience and machine learning to provide risk stratification for insurance carriers.

pymetrics

ACQUIRED. Pymetrics develops neuroscience-based human capital assessment software that enables companies to hire the best employees.

Roken

Reken is building a new category of products and platforms to protect against generative AI attacks.

robust-ai

Robust AI is developing the world's first industrial-grade cognitive engine for robots that work collaboratively with humans.

sounding-board

Sounding Board is a leadership development platform that combines technology and coaching to drive meaningful business impact.

swing

Swing is a virtual clinic that leverages evidenced-based holistic treatment for patients living with fibromyalgia.

the-meta

ACQUIRED. The Meta is a science-driven advanced simulation system for skill development, training, and peak performance.

thrive-global

Thrive Global provides enterprisse software to unlock and sustain peak performance through sustainable behavior change.

tomato-AI

Tomato AI leverages generative AI to improve human speech, initially focused on international customer support agents.

transcriptabio

Transcripta leverages cutting-edge technology and biology to discover and develop new therapies.

two-bit-circus

Two Bit Circus is an experiential entertainment company that unlocks our potential to enjoy ourselves in amazing new ways.

virb

Virb is the first talent-as-a-service platform that supports clinical research globally.

wade-wendy

ACQUIRED. Wade & Wendy leverages AI to optimize the process of matching job-seekers with employers.

wisdo-health

Wisdo connects people with shared life experiences and aggregates the world’s wisdom.

woebot

Woebot is the leader in artificial intelligence-driven care for mental health and wellbeing.

yumi

Yumi delivers scientifically validated nutrition optimized for developing bodies and brains.

zeitworks

ACQUIRED. Zeitworks leverages advanced AI to develop enterprise software that maximizes human potential at work.

zus

Zus Health is the only shared health data platform designed to accelerate healthcare data interoperability.

air

AIR uses closed-loop interactions to provide a robust training platform for humans and AI agents to collaborate and learn together.

akili

IPO. Akili Interactive develops scientifically validated, entertaining videogames designed to improve mental capabilities.

all-stripes

ACQUIRED. AllStripes is a digital research platform for unlocking new treatments for people with rare disease.

applied-vr

AppliedVR is pioneering next-generation prescription digital therapeutics for pain management and mental health.

arrival-health

Arrive Health provides critical information and clinical decision support technology at the point of care.

augment

Augment leverages AI to supercharge human productivity.

BioDrive is a gene editing company developing supplements that improve human health and wellness.

blue-note-therapeutics

Blue Note leverages cutting-edge digital technology and neuroscience for the treatment of serious medical conditions.

cadence-neuroscience

Cadence Neuroscience is developing a brain-computer interface (BCI) platform to treat a wide range of neurological disorders.

colossal

Colossal is a technology-driven biosciences platform advancing CRISPR technology to increase biodiversity and treat disease.

count

Count Technologies is developing AI-enabled tools to augment workforce productivity in financial services.

embodied

Embodied is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care.

enveda-biosciences

Enveda Biosciences leverages AI and metabolomics to translate molecules found in nature into new therapeutics.

eye-fluence

ACQUIRED. Eyefluence created the world’s first eye-interaction solution for augmented and virtual reality devices.

form-bio

Form Bio is the new operating system for the biological sciences.

forsight

Foresight augments human performance by providing state-of-the-art technology-driven mental healthcare services.

free-letics

Freeletics is the market leader in personalized coaching intelligence for optimizing physical fitness.

genesis-therapeutics

Genesis Therapeutics leverages machine learning to accelerate and optimize the discovery and development of new medicines.

halo-neuroscience

ACQUIRED. Halo Neuroscience uses brain stimulation to improve physical performance.

her-MD

HerMD is a technology-enabled female-focused provider of comprehensive and empathic healthcare for women.

human-co

HumanCo builds products focused on sustainable healthier living.

insight-timer

Insight Timer is a global meditation marketplace with over 40,000 guided meditations and 25 million members.

intuition

Intuition is a technology platform that drives human performance and wellness in the workplace.

job-get

JobGet is a mobile social jobs platform for the 82 million hourly workers in the US.

klowen

KLOwen is creating the future of digitally-enabled orthodontia.

League1 is establishing a first-of-its-kind sports league focused on fan experience and athlete safety.

level-ex

ACQUIRED. Level Ex creates industry-leading mobile and AR training software and games for physicians.

limbix

ACQUIRED. Limbix develops software to treat adolescent mental health.

magic-mind

Magic Mind provides clinically validated alternatives to high-caffeine energy drinks to improve cognitive function and wellbeing.

magnus-medical

Magnus Medical is developing closed-loop neuromodulation technology to treat intractable neurological and psychiatric disorders.

mahana

Mahana is developing breakthrough digital therapeutics that treat diseases, relieve suffering, and improve human performance.

mercaso

Mercaso develops software and automation technology to unlock the potential of small businesses.

merly_ai

Merly develops machine programming software intended to automate software development and improve software quality.

nextstep

ACQUIRED. NextStep developed accelerated learning technology to enable workers in less-skilled jobs to unlock their full potential.

oma-fertility

ACQUIRED. Oma has clinics that offer empathic care powered by AI technologies to increase IVF success rates at much lower costs.

oura

Oura is the leader in technologies that analyze sleep and activity to optimize human performance.

outside

Outside is the leader in technology and media innovation for active lifestyle enthusiasts.

pear-therapeutics

IPO. Pear Therapeutics is pioneering the development of prescription digital therapeutics.

Picnic-Health

PicnicHealth collects, digitizes, and encrypts all your medical records—then arranges everything in one intuitive timeline.

pinpoint

Pinpoint Predictive leverages neuroscience and machine learning to provide risk stratification for insurance carriers.

pymetrics

ACQUIRED. Pymetrics develops neuroscience-based human capital assessment software that enables companies to hire the best employees.

Roken

Reken is building a new category of products and platforms to protect against generative AI attacks.

robust-ai

Robust AI is developing the world's first industrial-grade cognitive engine for robots that work collaboratively with humans.

sounding-board

Sounding Board is a leadership development platform that combines technology and coaching to drive meaningful business impact.

swing

Swing is a virtual clinic that leverages evidenced-based holistic treatment for patients living with fibromyalgia.

the-meta

ACQUIRED. The Meta is a science-driven advanced simulation system for skill development, training, and peak performance.

thrive-global

Thrive Global provides enterprisse software to unlock and sustain peak performance through sustainable behavior change.

tomato-AI

Tomato AI leverages generative AI to improve human speech, initially focused on international customer support agents.

transcriptabio

Transcripta leverages cutting-edge technology and biology to discover and develop new therapies.

two-bit-circus

Two Bit Circus is an experiential entertainment company that unlocks our potential to enjoy ourselves in amazing new ways.

virb

Virb is the first talent-as-a-service platform that supports clinical research globally.

wade-wendy

ACQUIRED. Wade & Wendy leverages AI to optimize the process of matching job-seekers with employers.

wisdo-health

Wisdo connects people with shared life experiences and aggregates the world’s wisdom.

woebot

Woebot is the leader in artificial intelligence-driven care for mental health and wellbeing.

yumi

Yumi delivers scientifically validated nutrition optimized for developing bodies and brains.

zeitworks

ACQUIRED. Zeitworks leverages advanced AI to develop enterprise software that maximizes human potential at work.

zus

Zus Health is the only shared health data platform designed to accelerate healthcare data interoperability.

AIR uses closed-loop interactions to provide a robust training platform for humans and AI agents to collaborate and learn together.

view site

AppliedVR is pioneering next-generation prescription digital therapeutics for pain management and mental health.

view site

Augment leverages AI to supercharge human productivity.

view site

BioDrive is a gene editing company developing supplements that improve human health and wellness.

view site

Count Technologies is developing AI-enabled tools to augment workforce productivity in financial services.

view site

Embodied is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care.

view site

ACQUIRED. Eyefluence created the world’s first eye-interaction solution for augmented and virtual reality devices.

Form Bio is the new operating system for the biological sciences.

view site

Intuition is a technology platform that drives human performance and wellness in the workplace.

view site

JobGet is a mobile social jobs platform for the 82 million hourly workers in the US.

view site

League1 is establishing a first-of-its-kind sports league focused on fan experience and athlete safety.

view site

ACQUIRED. Level Ex creates industry-leading mobile and AR training software and games for physicians.

view site

Magic Mind provides clinically validated alternatives to high-caffeine energy drinks to improve cognitive function and wellbeing.

view site

Mercaso develops software and automation technology to unlock the potential of small businesses.

view site

Merly develops machine programming software intended to automate software development and improve software quality.

view site

ACQUIRED. NextStep developed accelerated learning technology to enable workers in less-skilled jobs to unlock their full potential.

ACQUIRED. Oma has clinics that offer empathic care powered by AI technologies to increase IVF success rates at much lower costs.

Oura is the leader in technologies that analyze sleep and activity to optimize human performance.

view site

Pinpoint Predictive leverages neuroscience and machine learning to provide risk stratification for insurance carriers.

view site

ACQUIRED. Pymetrics develops neuroscience-based human capital assessment software that enables companies to hire the best employees.

view site

Reken is building a new category of products and platforms to protect against generative AI attacks.

view site

Robust AI is developing the world's first industrial-grade cognitive engine for robots that work collaboratively with humans.

view site

Sounding Board is a leadership development platform that combines technology and coaching to drive meaningful business impact.

view site

ACQUIRED. The Meta is a science-driven advanced simulation system for skill development, training, and peak performance.

Thrive Global provides enterprisse software to unlock and sustain peak performance through sustainable behavior change.

view site

Tomato AI leverages generative AI to improve human speech, initially focused on international customer support agents.

view site

Two Bit Circus is an experiential entertainment company that unlocks our potential to enjoy ourselves in amazing new ways.

view site

Virb is the first talent-as-a-service platform that supports clinical research globally.

view site

ACQUIRED. Wade & Wendy leverages AI to optimize the process of matching job-seekers with employers.

Yumi delivers scientifically validated nutrition optimized for developing bodies and brains.

view site

ACQUIRED. Zeitworks leverages advanced AI to develop enterprise software that maximizes human potential at work.

Zus Health is the only shared health data platform designed to accelerate healthcare data interoperability.

view site

IPO. Akili Interactive develops scientifically validated, entertaining videogames designed to improve mental capabilities.

view site

ACQUIRED. AllStripes is a digital research platform for unlocking new treatments for people with rare disease.

view site

AppliedVR is pioneering next-generation prescription digital therapeutics for pain management and mental health.

view site

Arrive Health provides critical information and clinical decision support technology at the point of care.

view site

Blue Note leverages cutting-edge digital technology and neuroscience for the treatment of serious medical conditions.

Cadence Neuroscience is developing a brain-computer interface (BCI) platform to treat a wide range of neurological disorders.

view site

Colossal is a technology-driven biosciences platform advancing CRISPR technology to increase biodiversity and treat disease.

view site

Embodied is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care.

view site

Enveda Biosciences leverages AI and metabolomics to translate molecules found in nature into new therapeutics.

view site

Form Bio is the new operating system for the biological sciences.

view site

Foresight augments human performance by providing state-of-the-art technology-driven mental healthcare services.

view site

Freeletics is the market leader in personalized coaching intelligence for optimizing physical fitness.

view site

Genesis Therapeutics leverages machine learning to accelerate and optimize the discovery and development of new medicines.

view site

ACQUIRED. Halo Neuroscience uses brain stimulation to improve physical performance.

view site

HerMD is a technology-enabled female-focused provider of comprehensive and empathic healthcare for women.

view site

HumanCo builds products focused on sustainable healthier living.

view site

Insight Timer is a global meditation marketplace with over 40,000 guided meditations and 25 million members.

view site

KLOwen is creating the future of digitally-enabled orthodontia.

view site

League1 is establishing a first-of-its-kind sports league focused on fan experience and athlete safety.

view site

ACQUIRED. Limbix develops software to treat adolescent mental health.

view site

Magic Mind provides clinically validated alternatives to high-caffeine energy drinks to improve cognitive function and wellbeing.

view site

Magnus Medical is developing closed-loop neuromodulation technology to treat intractable neurological and psychiatric disorders.

view site

Mahana is developing breakthrough digital therapeutics that treat diseases, relieve suffering, and improve human performance.

view site

Oura is the leader in technologies that analyze sleep and activity to optimize human performance.

view site

Outside is the leader in technology and media innovation for active lifestyle enthusiasts.

view site

IPO. Pear Therapeutics is pioneering the development of prescription digital therapeutics.

PicnicHealth collects, digitizes, and encrypts all your medical records—then arranges everything in one intuitive timeline.

view site

Swing is a virtual clinic that leverages evidenced-based holistic treatment for patients living with fibromyalgia.

view site

Thrive Global provides enterprisse software to unlock and sustain peak performance through sustainable behavior change.

view site

Transcripta leverages cutting-edge technology and biology to discover and develop new therapies.

view site

Wisdo connects people with shared life experiences and aggregates the world’s wisdom.

view site

Woebot is the leader in artificial intelligence-driven care for mental health and wellbeing.

view site

Yumi delivers scientifically validated nutrition optimized for developing bodies and brains.

view site

Zus Health is the only shared health data platform designed to accelerate healthcare data interoperability.

view site

AIR uses closed-loop interactions to provide a robust training platform for humans and AI agents to collaborate and learn together.

view site

IPO. Akili Interactive develops scientifically validated, entertaining videogames designed to improve mental capabilities.

view site

ACQUIRED. AllStripes is a digital research platform for unlocking new treatments for people with rare disease.

view site

AppliedVR is pioneering next-generation prescription digital therapeutics for pain management and mental health.

view site

Arrive Health provides critical information and clinical decision support technology at the point of care.

view site

Augment leverages AI to supercharge human productivity.

view site

BioDrive is a gene editing company developing supplements that improve human health and wellness.

view site

Blue Note leverages cutting-edge digital technology and neuroscience for the treatment of serious medical conditions.

Cadence Neuroscience is developing a brain-computer interface (BCI) platform to treat a wide range of neurological disorders.

view site

Colossal is a technology-driven biosciences platform advancing CRISPR technology to increase biodiversity and treat disease.

view site

Count Technologies is developing AI-enabled tools to augment workforce productivity in financial services.

view site

Embodied is a robotics and AI company creating state-of-the-art companion robots to revolutionize human-centric care.

view site

Enveda Biosciences leverages AI and metabolomics to translate molecules found in nature into new therapeutics.

view site

ACQUIRED. Eyefluence created the world’s first eye-interaction solution for augmented and virtual reality devices.

Form Bio is the new operating system for the biological sciences.

view site

Foresight augments human performance by providing state-of-the-art technology-driven mental healthcare services.

view site

Freeletics is the market leader in personalized coaching intelligence for optimizing physical fitness.

view site

Genesis Therapeutics leverages machine learning to accelerate and optimize the discovery and development of new medicines.

view site

ACQUIRED. Halo Neuroscience uses brain stimulation to improve physical performance.

view site

HerMD is a technology-enabled female-focused provider of comprehensive and empathic healthcare for women.

view site

HumanCo builds products focused on sustainable healthier living.

view site

Insight Timer is a global meditation marketplace with over 40,000 guided meditations and 25 million members.

view site

Intuition is a technology platform that drives human performance and wellness in the workplace.

view site

JobGet is a mobile social jobs platform for the 82 million hourly workers in the US.

view site

KLOwen is creating the future of digitally-enabled orthodontia.

view site

League1 is establishing a first-of-its-kind sports league focused on fan experience and athlete safety.

view site

ACQUIRED. Level Ex creates industry-leading mobile and AR training software and games for physicians.

view site

ACQUIRED. Limbix develops software to treat adolescent mental health.

view site

Magic Mind provides clinically validated alternatives to high-caffeine energy drinks to improve cognitive function and wellbeing.

view site

Magnus Medical is developing closed-loop neuromodulation technology to treat intractable neurological and psychiatric disorders.

view site

Mahana is developing breakthrough digital therapeutics that treat diseases, relieve suffering, and improve human performance.

view site

Mercaso develops software and automation technology to unlock the potential of small businesses.

view site

Merly develops machine programming software intended to automate software development and improve software quality.

view site

ACQUIRED. NextStep developed accelerated learning technology to enable workers in less-skilled jobs to unlock their full potential.

ACQUIRED. Oma has clinics that offer empathic care powered by AI technologies to increase IVF success rates at much lower costs.

Oura is the leader in technologies that analyze sleep and activity to optimize human performance.

view site

Outside is the leader in technology and media innovation for active lifestyle enthusiasts.

view site

IPO. Pear Therapeutics is pioneering the development of prescription digital therapeutics.

PicnicHealth collects, digitizes, and encrypts all your medical records—then arranges everything in one intuitive timeline.

view site

Pinpoint Predictive leverages neuroscience and machine learning to provide risk stratification for insurance carriers.

view site

ACQUIRED. Pymetrics develops neuroscience-based human capital assessment software that enables companies to hire the best employees.

view site

Reken is building a new category of products and platforms to protect against generative AI attacks.

view site

Robust AI is developing the world's first industrial-grade cognitive engine for robots that work collaboratively with humans.

view site

Sounding Board is a leadership development platform that combines technology and coaching to drive meaningful business impact.

view site

Swing is a virtual clinic that leverages evidenced-based holistic treatment for patients living with fibromyalgia.

view site

ACQUIRED. The Meta is a science-driven advanced simulation system for skill development, training, and peak performance.

Thrive Global provides enterprisse software to unlock and sustain peak performance through sustainable behavior change.

view site

Tomato AI leverages generative AI to improve human speech, initially focused on international customer support agents.

view site

Transcripta leverages cutting-edge technology and biology to discover and develop new therapies.

view site

Two Bit Circus is an experiential entertainment company that unlocks our potential to enjoy ourselves in amazing new ways.

view site

Virb is the first talent-as-a-service platform that supports clinical research globally.

view site

ACQUIRED. Wade & Wendy leverages AI to optimize the process of matching job-seekers with employers.

Wisdo connects people with shared life experiences and aggregates the world’s wisdom.

view site

Woebot is the leader in artificial intelligence-driven care for mental health and wellbeing.

view site

Yumi delivers scientifically validated nutrition optimized for developing bodies and brains.

view site

ACQUIRED. Zeitworks leverages advanced AI to develop enterprise software that maximizes human potential at work.

Zus Health is the only shared health data platform designed to accelerate healthcare data interoperability.

view site

JAZZ is headquartered in San Francisco and has offices in Seattle, Santa Barbara, and Miami.

Email:

info@jazzvp.com

Headquarters:

2 Jack London Alley
San Francisco, CA 94107
view map